<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="https://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="https://www.google.com/schemas/sitemap-image/1.1">
	<url>
		<loc>https://cancercaseconference.com/</loc>
		<lastmod>2024-12-24T17:08:11+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/trials/</loc>
		<lastmod>2025-03-20T19:34:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/contact/</loc>
		<lastmod>2023-02-25T22:08:45+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/about/</loc>
		<lastmod>2023-02-25T22:04:45+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/meet-the-investigators/</loc>
		<lastmod>2024-10-17T21:15:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/clinicaltrials-gov/</loc>
		<lastmod>2021-11-15T19:07:35+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/osimertinib-with-or-without-bevacizumab-as-initial-treatment-for-patients-with-egfr-mutant-lung-cancer/</loc>
		<lastmod>2024-12-03T20:45:09+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/doxorubicin-hydrochloride-and-cyclophosphamide-followed-by-paclitaxel-with-or-without-carboplatin-in-treating-patients-with-triple-negative-breast-cancer/</loc>
		<lastmod>2024-12-03T20:45:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/testing-the-addition-of-radiotherapy-to-the-usual-treatment-chemotherapy-for-patients-with-esophageal-and-gastric-cancer-that-has-spread-to-a-limited-number-of-other-places-in-the-body/</loc>
		<lastmod>2024-12-03T20:44:22+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/other-clinical-trials/</loc>
		<lastmod>2024-04-26T19:47:36+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/provider-resources/</loc>
		<lastmod>2025-03-05T18:28:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/citi-program/</loc>
		<lastmod>2023-02-25T22:07:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/florence-ebinders/</loc>
		<lastmod>2023-02-25T22:15:15+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/biosketch-with-sciencv/</loc>
		<lastmod>2023-02-25T22:05:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/cancer-trials-support-unit-ctsu/</loc>
		<lastmod>2023-02-25T22:06:31+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/t-dm1-and-tucatinib-compared-with-t-dm1-alone-in-preventing-relapses-in-people-with-high-risk-her2-positive-breast-cancer-the-compassher2-rd-trial/</loc>
		<lastmod>2024-12-03T20:43:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/current-svmhs-research-protocols/</loc>
		<lastmod>2024-11-25T23:14:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/protocol-builder/</loc>
		<lastmod>2022-01-25T17:57:47+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/recist-1-1-guidelines-tools-training/</loc>
		<lastmod>2023-02-25T22:23:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/test-post/</loc>
		<lastmod>2022-03-30T23:31:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/643-2/</loc>
		<lastmod>2024-12-03T20:42:25+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/regional-radiotherapy-in-biomarker-low-risk-node-positive-and-t3n0-breast-cancer-tailor-rt/</loc>
		<lastmod>2024-12-03T20:41:26+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/cancer-conferences/</loc>
		<lastmod>2024-12-20T17:38:34+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/643-2-2-2/</loc>
		<lastmod>2024-12-03T20:40:33+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/643-2-2/</loc>
		<lastmod>2024-12-03T20:36:06+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/oncology-journal-club/</loc>
		<lastmod>2025-03-20T19:30:56+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/a012103-pembrolizumab-vs-observation-in-people-with-triple-negative-breast-cancer-who-had-a-pathologic-complete-response-after-chemotherapy-plus-pembrolizumab/</loc>
		<lastmod>2024-12-03T20:35:05+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/a012103-pembrolizumab-vs-observation-in-people-with-triple-negative-breast-cancer-who-had-a-pathologic-complete-response-after-chemotherapy-plus-pembrolizumab-2/</loc>
		<lastmod>2024-12-03T20:33:36+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02/</loc>
		<lastmod>2024-12-03T20:31:59+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/nctn-breast-cancer-trials-portfolio-for-salinas-valley-health/</loc>
		<lastmod>2024-02-26T22:51:38+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2/</loc>
		<lastmod>2024-12-03T20:30:56+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/clinical-trials-protocols/</loc>
		<lastmod>2024-05-31T17:53:40+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2/</loc>
		<lastmod>2024-12-03T19:56:51+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2/</loc>
		<lastmod>2024-12-03T19:55:44+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3/</loc>
		<lastmod>2024-12-03T19:54:04+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-2-2/</loc>
		<lastmod>2024-12-03T19:53:06+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-2-2-2/</loc>
		<lastmod>2024-12-03T19:50:07+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3-2/</loc>
		<lastmod>2024-12-03T19:52:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3-2-2/</loc>
		<lastmod>2024-12-03T19:51:04+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3-2-2-2/</loc>
		<lastmod>2024-12-03T19:49:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-2-3/</loc>
		<lastmod>2024-12-03T19:59:28+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-2-3-2/</loc>
		<lastmod>2024-12-03T19:59:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-2-3-2-2/</loc>
		<lastmod>2024-12-03T19:58:02+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/jit/</loc>
		<lastmod>2024-08-28T20:51:56+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3-2-2-2-2/</loc>
		<lastmod>2024-12-03T19:47:22+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3-2-2-2-2-2/</loc>
		<lastmod>2024-12-03T19:45:18+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/new-frontiers-in-our-oncology-research/</loc>
		<lastmod>2024-10-03T19:58:39+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-2-3-2-2-2/</loc>
		<lastmod>2025-01-15T18:50:55+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/observational-basket-trial-to-collect-tissue-to-train-and-validate-a-live-tumor-diagnostic-platform-cybrid-02-2-2-2-3-2-2-2-3/</loc>
		<lastmod>2024-12-03T19:40:03+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/current-news-rss-feeds/</loc>
		<lastmod>2025-03-20T19:41:11+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
	<url>
		<loc>https://cancercaseconference.com/cancer-research-at-salinas-valley-health/</loc>
		<lastmod>2025-03-06T00:02:24+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.8</priority>
	</url>
</urlset>